期刊
ACTA HAEMATOLOGICA
卷 144, 期 1, 页码 10-23出版社
KARGER
DOI: 10.1159/000510178
关键词
COVID-19; SARS-CoV-2; Lymphopenia; Coagulation; Review
类别
COVID-19, caused by SARS-CoV-2, is impacting millions worldwide and leading to various hematological abnormalities in infected patients, posing challenges in the management of patients with hematological disorders.
Coronavirus disease 2019 (COVID-19) is affecting millions of patients worldwide. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the family Coronaviridae, with 80% genomic similarities to SARS-CoV. Lymphopenia was commonly seen in infected patients and has a correlation to disease severity. Thrombocytopenia, coagulation abnormalities, and disseminated intravascular coagulation were observed in COVID-19 patients, especially those with critical illness and non-survivors. This pandemic has caused disruption in communities and hospital services, as well as straining blood product supply, affecting chemotherapy treatment and haematopoietic stem cell transplantation schedule. In this article, we review the haematological manifestations of the disease and its implication on the management of patients with haematological disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据